All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Security
Security
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

Imaging in Semaglutide Study

Conditions : Type 2 Diabetes; BMI Greater Than 30 Interventions : Radiation: 31P-MRS and MRI Sponsors : The Cleveland Clinic Not yet recruiting

Read the full article
16h agoen

You might also wanna read

Semaglutide Shows Chondroprotective Effects in Osteoarthritis Through Weight Loss-Independent Metabolic Mechanism

Qin et al. demonstrated the chondroprotective effects of semaglutide in obesity-related osteoarthritis. Mechanistically, these effects are i

cell.com·4mo ago

Study: GLP-1 drugs like semaglutide linked to lower amputation risk in diabetes patients with peripheral artery disease

A new study suggests GLP-1 medications, such as semaglutide, were associated with better overall outcomes in people with type 2 diabetes and

medicalnewstoday.com·7d ago

ADA 2026: New GLP-1 Oral Drug, Semaglutide-Amylin Combo, and Chinese Mazdutide Data Highlighted

This Medical News article is an interview with Rita Kalyani, MD, MHS, the American Diabetes Association’s chief scientific and medical offic

ja.ma·21d ago

Semaglutide slows epigenetic aging in a randomized trial of HIV-associated lipohypertrophy

Semaglutide slows epigenetic aging in HIV-associated lipohypertrophy. In a 32-week trial, 45 on semaglutide vs. 39 on placebo showed promisi

doi.org·18d ago

REIMAGINE trials demonstrate efficacy of combination therapy for treating type 2 diabetes

Donna Ryan, MD, and other panelists reported on new data from phase 3 trials evaluating the combination of cagrilintide, which mimics amylin

adameetingnews.org·1mo ago

ADA 2026 Scientific Sessions: New GLP-1 Drugs and Diabetes Research Highlights

Rita Kalyani, MD, chief scientific and medical officer at the American Diabetes Association, discusses the latest diabetes and obesity resea

ja.ma·20d ago

Comments

Sign in to join the conversation.

No comments yet. Be the first.